Endocrinology, Vol 121, 1306-1311, Copyright © 1987 by Endocrine Society

ARTICLES

The insulin-like growth factor-II (IGF II) receptor from rat brain is of lower apparent molecular weight than the IGF II receptor from rat liver

A McElduff, P Poronnik and RC Baxter
Department of Endocrinology, Royal North Shore Hospital, Sydney, Australia.

The binding subunits of the insulin and insulin-like growth factor-I (IGF I) receptors from rat brain are of lower molecular weight than the corresponding receptor in rat liver, possibly due to variations in sialic acid content. We have compared the IGF II receptor from rat brain and rat liver. The brain receptor is of smaller apparent mol wt (about 10 K) on sodium dodecyl sulfate polyacrylamide gel electrophoresis. This size difference is independent of ligand binding as it persists in iodinated and specifically immunoprecipitated receptors. From studies of wheat germ agglutinin binding and the effect of neuraminidase on receptor mobility, we conclude that this difference is not simply due to variations in sialic acid content. Treatment with endoglycosidase F results in reduction in the molecular size of both liver and brain receptors and after this treatment the aglycoreceptors are of similar size. We conclude that in rat brain tissue the IGF II receptor like the binding subunits of the insulin and IGF I receptors is of lower molecular size than the corresponding receptors in rat liver. This difference is due to differences in N-linked glycosylation.

This article has been cited by other articles:

				D. Muller, R. Middendorff, J. Olcese, and A. K. Mukhopadhyay Central Nervous System-Specific Glycosylation of the Type A Natriuretic Peptide Receptor Endocrinology, January 1, 2002; 143(1): 23 - 29. [Abstract] [Full Text] [PDF]